Author

Martha Skup 1

1 Abbvie Inc., North Chicago, United States

ADALIMUMAB LONG-TERM EFFECTIVENESS IN ADALIMUMAB-NAIVE PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY

Edward V Loftus Jr, Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Remo Panaccione, Sofie Berg, Gabriela Alperovich, Mareike Bereswill, Jasmina Kalabic, Martha Skup, Joel Petersson, Anne M. Robinson

COST-EFFECTIVENESS OF ADALIMUMAB IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (SUB-ACUTE) IN THE UK

Hongbo Yang, Alistair Curry, Song Wang, MIn A. Yang, Martha Skup, Jingdong Chao, Yanjun Bao

DISCORDANCE BETWEEN PATIENTS AND PHYSICIANS IN LONG-TERM USE OF STEROIDS: RESULTS FROM A PATIENT- AND PHYSICIAN-REPORTED SURVEY

Subrata Ghosh, Jill Petkau, Roopal B Thakkar, Jingdong Chao, Martha Skup, Song Wang, Remo Panaccione, Stefan Schreiber

DISEASE BURDEN AND FACTORS ASSOCIATED WITH ULCERATIVE COLITIS PROGRESSION IN SWEDEN

Jan Stålhammar, Per Hällström, Lars Agréus, Heval Beydogan, Lisen Arnheim Dahlström, Martha Skup, Wan-Ju Lee

EFFECT OF ADALIMUMAB ON CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES BY DISEASE SEVERITY AND PRIOR TUMOUR NECROSIS FACTOR INHIBITOR USE IN PATIENTS WITH ULCERATIVE COLITIS IN A CLINICAL PRACTICE SETTING: SUBGROUP ANALYSES FROM INSPIRADA

Simon Travis, Brian G. Feagan, Laurent Peyrin-Biroulet, Remo Panaccione, Silvio Danese, Joel Petersson, Andreas Lazar, Anne M. Robinson, Naijun Chen, Martha Skup, Wan-Ju Lee

EFFECT OF ADALIMUMAB ON PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS IN ITALIAN CLINICAL PRACTICE SETTING: RESULTS FROM INSPIRADA

Anna Kohn, Livia Biancone, Paolo Gionchetti, Silvio Danese, Ambrogio Orlando, Andreas Lazar, Anne M. Robinson, Brandee L Pappalardo, Mareike Bereswill, Martha Skup, Naijun Chen, Rocco Merolla, Song Wang, Roopal B Thakkar, Simon Travis

HOSPITALIZATION RATES IN PATIENTS WITH CROHN’S DISEASE AND DEEP REMISSION: DATA FROM THE 56-WEEK CHARM TRIAL

Jean-Frederic Colombel, Remo Panaccione, Edouard Louis, Mei Yang, Martha Skup, Roopal B Thakkar, Parvez Mulani, Jingdong Chao, William Sandborn

IMPACT OF NON-MEDICAL SWITCHING OF ANTI-TUMOR NECROSIS FACTOR AGENTS ON HEALTHCARE COSTS IN EUROPE

Timothy Juday, Martha Skup, Chris Streuper, Ulrik Gregers Winther Mørch, Gry Stine Kopperud, Ole Henriksen, Scott Johnson, Thomas O'Connell

INDIRECT COMPARISON OF ADALIMUMAB AND VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM: COST PER RESPONDER/REMITTER ANALYSIS

Yifei Liu, William Reichmann, Song Wang, Dendy Macaulay, Martha Skup, Jingdong Chao, Yanjun Bao

LONG-TERM EFFECTIVENESS OF ADALIMUMAB IN CROHN’S DISEASE: OBSERVATIONAL DATA FROM THE PYRAMID REGISTRY

Edward Loftus, Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Remo Panaccione, Roopal B Thakkar, Samantha Eichner, Majin M. Castillo, Natalia Kan-Dobrosky, Martha Skup, Parvez Mulani, Jingdong Chao

Item 1 - 10 / 20
1
2